«Insilico Medicine»
Insilico Medicine
Companies
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Investors
4DX Ventures
500 Startups Canada
A-Level Capital
Ascent Venture Partners
B Capital Group
Baidu Ventures
Blue Ocean Capital
Bold Capital Partners
CPE
Creative Ventures
Deep Knowledge Group
Deep Knowledge Ventures
Deerfield Management
Domain Associates
Eight Roads Ventures
EPIC Ventures
F-Prime Capital
Flying Fish Partners
Flyover Capital
FMO
Focus Media
Folius Ventures
Fonds de solidarité FTQ
Formic Ventures
Fosun Pharma
Foundamental
Foundation Capital
Foundation for Technological Innovation (FIT)
Founder Collective
Founder Institute
Founders Factory
Founders Factory Africa
Founders Fund
Founders Future
FoundersX Ventures
FPrime Capital
Harmonix Fund
HPE Growth
Hunt BioVentures
IKIGAI
Jim Mellon
Juvenescence
Lake Bleu Capital
Lilly Asia Ventures
LongeVC
Longevity Vision Fund
Maison Capital
Mercia Fund Managers
Mirae Asset Capital
MKaNN
Neue Fund
OrbiMed
Pavilion Capital
Poolz Finance
Porsche
Portage Ventures
President International Development Corporation
Prosperity7 Ventures
Qihoo 360 Technology
Qiming Venture Partners
Qiming Venture Partners USA
Sage Partners
Scale AI
seed + speed Ventures
Semtech
Sequoia Capital China
Sinovation Ventures
Team8
Tech Coast Angels
Tech Invest Com
Tech Pioneers Fund
Tech Square Ventures
Tech2b Incubator
Varaprasad Reddy
Warburg Pincus
Wharton Asset Management Company Limited
Wilson Sonsini Goodrich & Rosati
WuXi AppTec
Xavier Castells
Zhongyuan Union Cell & Gene Eng
Connections
Heckyl
Connections from
Archangel Imaging
Center Health
Cognitive Finance Group
GeoSpock
Lifebit
Pace
Industry:
Global Health Challenges
Headquarters:
Hong Kong
Visit Website
ai@insilico.com
Register and Claim Ownership